Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4587145 | 0.89 | EGFR (1.00) | EGFRERBB2 | |
| Hydrochloric Acid SCHEMBL6241661 | 0.89 | EGFR (0.98) | EGFRERBB2 | |
| SCHEMBL17075899 | 0.84 | EGFR (0.59) | EGFRERBB2 | |
| Hydrochloric Acid SCHEMBL8809228 | 0.81 | EGFR (0.59) | EGFRERBB2 | |
| Hydrochloric Acid SCHEMBL8809603 | 0.81 | EGFR (0.67) | EGFRERBB2 | |
| SCHEMBL9910666 | 0.78 | EGFR (0.66) | EGFRERBB2 | |
| SCHEMBL8933754 | 0.77 | EGFR (0.80) | EGFRERBB2 | |
| SCHEMBL3017545 | 0.77 | EGFR (0.59) | EGFRERBB2 | |
| SCHEMBL3318952 | 0.77 | EGFR (0.65) | EGFRERBB2 | |
| Hydrochloric Acid SCHEMBL8810665 | 0.76 | EGFR (0.79) | EGFRERBB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150259331-A1 | PROTOZOAN PARASITE GROWTH INHIBITORS | THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 2015-09-17 | — | — | US | disclosed |
| US-20150259331-A1 | PROTOZOAN PARASITE GROWTH INHIBITORS | THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 2015-09-17 | — | — | US | disclosed |
| US-20150259331-A1 | PROTOZOAN PARASITE GROWTH INHIBITORS | THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 2015-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150259331-A1 | PROTOZOAN PARASITE GROWTH INHIBITORS | TPP1, MKI67, PIGO | EGFR 4389/4885ERBB2 4468/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.